These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 342858)

  • 1. Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits?
    Wise RA
    Life Sci; 1978 Feb; 22(7):535-42. PubMed ID: 342858
    [No Abstract]   [Full Text] [Related]  

  • 2. Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits.
    Fouriezos G; Wise RA
    Brain Res; 1976 Feb; 103(2):377-80. PubMed ID: 1252926
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: evidence for mediation by motor deficits rather than by reduced reward.
    Fibiger HC; Carter DA; Phillips AG
    Psychopharmacology (Berl); 1976 May; 47(1):21-7. PubMed ID: 959465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopamine and norepinephrine in the chemistry of reward.
    Fibiger HC; Phillips AG
    J Psychiatr Res; 1974; 11():135-43. PubMed ID: 4461785
    [No Abstract]   [Full Text] [Related]  

  • 5. Restoration of self-stimulation inhibited by neuroleptics.
    Wauquier A; Niemegeers CJ
    Eur J Pharmacol; 1976 Nov; 40(1):191-4. PubMed ID: 991925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced attenuation of brain stimulation reward in rats.
    Fouriezos G; Hansson P; Wise RA
    J Comp Physiol Psychol; 1978 Aug; 92(4):661-71. PubMed ID: 29060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit.
    Franklin KB; McCoy SN
    Pharmacol Biochem Behav; 1979 Jul; 11(1):71-5. PubMed ID: 493299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of peripheral and central dopamine blockade on lateral hypothalamic self-stimulation: evidence for both reward and motor deficits.
    Stellar JR; Kelley AE; Corbett D
    Pharmacol Biochem Behav; 1983 Mar; 18(3):433-42. PubMed ID: 6835998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antagonism of the effect of dopamine and norepinephrine on some isolated organs].
    Ferrini R; Miragoli G
    Boll Soc Ital Biol Sper; 1973 Jul; 49(11):648-52. PubMed ID: 4799566
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pimozide on positive and negative incentive contrast with rewarding brain stimulation.
    Phillips AG; LePiane FG
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1577-82. PubMed ID: 3737627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit.
    Fenton HM; Liebman JM
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1207-12. PubMed ID: 7163351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous rate-independent and rate-dependent assessment of intracranial self-stimulation: evidence for the direct involvement of dopamine in brain reinforcement mechanisms.
    Zarevics P; Setler PE
    Brain Res; 1979 Jun; 169(3):499-512. PubMed ID: 312681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dexetimide on pimozide-, haloperidol- and pipamperone-induced inhibition of brain self-stimulation in rats.
    Wauquier A; Niemegeers CJ
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):280-92. PubMed ID: 1190923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of the attentional and motivational effects of pimozide on the threshold for rewarding brain stimulation.
    Bird M; Kornetsky C
    Neuropsychopharmacology; 1990 Feb; 3(1):33-40. PubMed ID: 2137697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial self-stimulation in rats as a function of various stimulus parameters. II. Influence of haloperidol, pimozide and pipamperone on medial forebrain bundle stimulation with monopolar electrodes.
    Wauquier A; Niemegeers CJ
    Psychopharmacologia; 1972; 27(3):191-202. PubMed ID: 4642460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular effect of neuroleptics].
    Kuschinsky K
    Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
    [No Abstract]   [Full Text] [Related]  

  • 17. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and noradrenergic inhibition of hypothalamic self-stimulation: differentiation of reward and performance effects.
    Sinden JD; Atrens DM
    Eur J Pharmacol; 1982 Dec; 86(2):237-46. PubMed ID: 7160436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-neuroleptic interaction in brainstem self-stimulation.
    Rompré PP; Wise RA
    Brain Res; 1989 Jan; 477(1-2):144-51. PubMed ID: 2702479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pimozide on self-stimulation threshold under a continuous and fixed-interval schedule of reinforcement.
    Boye SM; Rompré PP
    Behav Brain Res; 1996 Aug; 78(2):243-5. PubMed ID: 8864057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.